Cost-effectiveness and public health impact of recombinant zoster vaccine versus no herpes zoster vaccination in selected populations of immunocompromised adults in Canada.
Saved in:
| Title: | Cost-effectiveness and public health impact of recombinant zoster vaccine versus no herpes zoster vaccination in selected populations of immunocompromised adults in Canada. |
|---|---|
| Authors: | George, Sydney1 (AUTHOR) sydneygee1@hotmail.com, Carrico, Justin2 (AUTHOR), Hicks, Katherine A.2 (AUTHOR), Loukov, Dessi1 (AUTHOR), Ng, Cheryl3 (AUTHOR), Curran, Desmond4 (AUTHOR) |
| Source: | BMC Health Services Research. 4/25/2025, Vol. 25 Issue 1, p1-13. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
